Jointown Pharmaceutical Group Co., Ltd

XSSC:600998 Stock Report

Market Cap: CN¥26.2b

Jointown Pharmaceutical Group Future Growth

Future criteria checks 1/6

Jointown Pharmaceutical Group is forecast to grow earnings and revenue by 17.1% and 8% per annum respectively. EPS is expected to grow by 15% per annum. Return on equity is forecast to be 10.4% in 3 years.

Key information

17.1%

Earnings growth rate

15.0%

EPS growth rate

Healthcare earnings growth23.1%
Revenue growth rate8.0%
Future return on equity10.4%
Analyst coverage

Low

Last updated08 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:600998 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026179,8703,082N/A4,2964
12/31/2025167,1702,721N/A2,2545
12/31/2024156,3732,353N/A4,5154
9/30/2024149,2052,0473171,291N/A
6/30/2024147,9532,039821,029N/A
3/31/2024148,5192,1513,1554,116N/A
12/31/2023150,1402,1743,6994,748N/A
9/30/2023151,8422,1705,2176,257N/A
6/30/2023151,7972,1595,4096,559N/A
3/31/2023147,3662,1942,3953,611N/A
12/31/2022140,4242,0852,7433,986N/A
9/30/2022133,2601,7823,6384,886N/A
6/30/2022128,4111,5451,3452,656N/A
3/31/2022124,9292,1411,8623,234N/A
12/31/2021122,4072,4482,0733,459N/A
9/30/2021122,6343,3392821,907N/A
6/30/2021121,4913,9883,1134,802N/A
3/31/2021116,3153,2582,0093,574N/A
12/31/2020110,8603,0751,9873,444N/A
9/30/2020106,4382,8492,9304,117N/A
6/30/2020102,4172,2422,0253,152N/A
3/31/2020102,0071,9762,3493,480N/A
12/31/201999,4971,7271,5762,768N/A
9/30/201996,7691,5881,4792,737N/A
6/30/201993,1161,5471,8823,123N/A
3/31/201989,5891,4465831,833N/A
12/31/201887,1361,341-5931,222N/A
9/30/201883,2301,262-1,949-231N/A
6/30/201880,1631,189N/A-2,213N/A
3/31/201877,3391,481N/A-2,221N/A
12/31/201773,9431,446N/A-1,012N/A
9/30/201770,7831,374N/A-2,586N/A
6/30/201767,9991,360N/A-198N/A
3/31/201764,925921N/A1,382N/A
12/31/201661,557877N/A431N/A
9/30/201658,367777N/A1,748N/A
6/30/201655,482754N/A193N/A
3/31/201653,091718N/A-783N/A
12/31/201549,589695N/A436N/A
9/30/201546,895640N/A-1,088N/A
6/30/201545,049602N/A-1,287N/A
3/31/201543,171566N/A-312N/A
12/31/201441,068561N/A-172N/A
9/30/201439,273533N/A-450N/A
6/30/201437,189509N/A-702N/A
3/31/201435,150493N/A-1,230N/A
12/31/201333,438478N/A138N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600998's forecast earnings growth (17.1% per year) is above the savings rate (2.8%).

Earnings vs Market: 600998's earnings (17.1% per year) are forecast to grow slower than the CN market (26.1% per year).

High Growth Earnings: 600998's earnings are forecast to grow, but not significantly.

Revenue vs Market: 600998's revenue (8% per year) is forecast to grow slower than the CN market (13.8% per year).

High Growth Revenue: 600998's revenue (8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600998's Return on Equity is forecast to be low in 3 years time (10.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y